La increíble espirulina

Authors

  • Richard Alexander Sera Blanco
  • Moraima García Díaz

Abstract

Según la Organización de las Naciones Unidas para la Alimentación y la Agricultura (FAO),1 la Espirulina, es una bacteria primitiva surgida hace aproximadamente 3.5 mil millones de años que ha adquirido la habilidad de utilizar el dióxido de carbono disuelto en el agua salada como fuente de nutriente para su reproducción. Es un Cianofito Fotosintetizador (cianobacteria) que crece vigorosamente bajo fuerte iluminación solar, a gran altura y en condiciones muy alcalinas.1 Aunque existen otras “cianobacterias” con propiedades similares, la familia de la Espirulina, cuyo término más aceptado desde 1997 es Artrospira, posee dos especies fundamentales la A. Máxima y la A. Platensis.

Downloads

Download data is not yet available.

References

Habib MAB, Parvin M, Huntington TC, Hasan MR. A review on culture, production and use of spirulina as food for humans and feeds for domestic animals and fish. 2008. Fao Fisheries and Aquaculture Circular [Internet]. 2008 [citado 6 May 2017];1034. Disponible en: ftp://ftp.fao.org/docrep/fao/011/i0424e/i0424e00.pdf

Lupatini AL, Colla LM, Canan C, Colla E. Potential application of microalga Spirulina platensis as a protein source. Journal of the Science of Food and Agriculture [Internet]. 2016 [citado 6 May 2017] Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/jsfa.7987/full

Abdulqader G, Barsanti L, Tredici M. R. Harvest of Arthrospira platensis from Lake Kossorom (Chad) and its household usage among the Kanembu. Journal of Applied Phycology [Internet]. 2000 [citado 6 May 2017];12:493-498. Disponible en: http://link.springer.com/article/10.1023/A:1008177925799

Sasson, A. Micro Biotechnologies: Recent Developments and Prospects for Developing Countries. BIOTEC Publication 1/2542 (11–31). Place de Fontenoy, Paris. United Nations Educational, Scientific and Cultural Organization (UNESCO). 1997.

Lupatini AL, Colla LM, Canan C, Colla E. Potential application of microalga Spirulina platensis as a protein source. Journal of Science of Food and Agriculture [Internet]. 2016 [citado 16 Ene 2017];97(3). Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/jsfa.7987/full

Liu Q, Huang Y, Zhang R, Cai T, Cai Y. Medical Application of Spirulina Platensis Derived C-Phycocyanin. Evidence-Based Complementary and Alternative Medicine [Internet]. 2016 [citado 16 Ene 2017];6. Disponible en: http://www.nature.com/articles/srep34564

Ouhtit A, Ismail MF, Othman A, Fernando A, Abdraboh ME, El-Kott AF, Azab YA, et al. Chemoprevention of Rat Mammary Carcinogenesis by Spirulina. Am J Pathol. 2014;184:296e303.

Liao G, Gao B, Gao Y, Yang X, Cheng X, Ou Y. Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy. Scientific Reports [Internet]. 2016 [citado 16 Ene 2017];6:34564. Disponible en: http://www.nature.com/articles/srep34564

U.S. Department of Health and Human Services. Assessing Cardiovascular Risk: systematic evidence review from the risk assessment work group, 2013. Seattle: National Institutes of Health; 2013.

Nagaoka S, Shimizu K, Kaneko H, Shibayama F, Morikawa K, Kanamaru Y, Otsuka A, et al. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J Nutr. 2005;135:2425–2430.

Serban MC, Sahebkar A, Dragan S, Stoichescu-Hogea G, Ursoniu S, Andrica F, Banach M. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin Nutr. 2016 Aug;35(4):842-51.

Ministerio de Salud Pública. Anuario Estadístico de Cuba 2015 [Internet]. La Habana: MINSAP; 2015 [citado 20 Ene 2017]. Disponible en: http://files.sld.cu/dne/files/2016/04/Anuario_2015_electronico-1.pdf

Downloads

Published

2017-01-15

How to Cite

1.
Sera Blanco RA, García Díaz M. La increíble espirulina. Medimay [Internet]. 2017 Jan. 15 [cited 2024 Nov. 5];24(1):87-90. Available from: https://medimay.sld.cu/index.php/rcmh/article/view/1045

Issue

Vol. 24 No. 1 (2017)

Section

UPDATED INFORMATION

License

Medimay protects copyright from the very first moment the submission is made, but upon publication it assumes a Creative Commons 4.0 (cc-by-nc) license, which allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build from the material) as long as exclusive mention is made of the publication in the journal as a primary source, prohibiting its commercialization. The author always retains his/her right.

Most read articles by the same author(s)

1 2 > >>